The DOI matches its Crossref record; 333 of the 333 references it cites were found in a registry or an index.
Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease
Abstract
Many people naturally assume that the claims made for foods and nutritional supplements have the same degree of scientific grounding as those for medication, but that is not always the case. The IOM recommends that the FDA adopt a consistent scientific framework for biomarker evaluation in order to achieve a rigorous and transparent process.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–333 of 333
CRP and the risk of atherosclerotic events
Calabrò, P., Golia, E., & Yeh, E. T. H. (2009) · Seminars in Immunopathology · doi:10.1007/s00281-009-0149-4 · Cited by 156
Emerging Biomarkers for the Diagnosis and Prognosis of Prostate Cancer
Sardana, G., Dowell, B. L., & Diamandis, E. P. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2008.110668 · Cited by 156
International federation of clinical chemistry
Pannall, P. R., Marshall, W., Jabor, A., & Magid, E. (1996) · Clinica Chimica Acta · doi:10.1016/0009-8981(95)06205-x · Cited by 155
Surrogate End Points in Clinical Research: Hazardous to Your Health
Grimes, D. A., & Schulz, K. F. (2005) · Obstetrics and Gynecology · doi:10.1097/01.aog.0000157445.67309.19 · Cited by 153
Singh, U. S., Devaraj, S., & Jialal, I. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000183718.62409.ea · Cited by 153
Oxygen toxicity: membrane damage by free radicals.
Feeney, L., & Berman, E. R. (1976) · PubMed · Cited by 148
Hepatology may have problems with putative surrogate outcome measures
Gluud, C. N., Brok, J. S., Gong, Y., & Koretz, R. L. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.01.003 · Cited by 148
Knopp, R. H., Paramsothy, P., Retzlaff, B. M., Fish, B., Walden, C., Dowdy, A., Tsunehara, C., Aikawa, K., & Cheung, M. C. (2005) · Current Atherosclerosis Reports · doi:10.1007/s11883-005-0065-6 · Cited by 148
The promise and peril of surrogate end points in cancer research
Schatzkin, A. G., & Gail, M. H. (2002) · Nature reviews. Cancer · doi:10.1038/nrc702 · Cited by 145
The Impact of a Nutrition Information Program on Food Purchases
Levy, A. S., Mathews, O., Stephenson, M. G., Tenney, J. E., & Schucker, R. E. (1985) · Journal of Public Policy & Marketing · doi:10.1177/074391568500400101 · Cited by 144
Strategic Approach to Fit-for-Purpose Biomarkers in Drug Development
Wagner, J. A. (2007) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.48.113006.094611 · Cited by 143
Performance Characteristics of Seven Nutrition Label Formats
Levy, A. S., Fein, S. B., & Schucker, R. E. (1996) · Journal of Public Policy & Marketing · doi:10.1177/074391569601500101 · Cited by 143
Consumers’ Ability to Perform Tasks Using Nutrition Labels
Levy, A. S., & Fein, S. B. (1998) · Journal of Nutrition Education · doi:10.1016/s0022-3182(98)70321-8 · Cited by 141
Rennie, D. (2004) · JAMA · doi:10.1001/jama.292.11.1359 · Cited by 139
Kaplan, I. V., & Levinson, S. S. (1999) · Clinical Chemistry · doi:10.1093/clinchem/45.5.616 · Cited by 138
Interrelationships Among HDL Metabolism, Aging, and Atherosclerosis
Walter, M. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.181438 · Cited by 137
Overview of Biomarkers and Surrogate Endpoints in Drug Development
Wagner, J. A. (2002) · Disease Markers · doi:10.1155/2002/929274 · Cited by 135
Horne, B. D., Muhlestein, J. B., Carlquist, J. F., Bair, T. L., Madsen, T. E., Hart, N. I., & Anderson, J. L. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00950-5 · Cited by 131
Gofman, J. W., DELALLA, O., Glazier, F., FREEMAN, N. K., Lindgren, F. T., Nichols, A. V., Strisower, B., & Tamplin, A. R. (2007) · Journal of clinical lipidology · doi:10.1016/j.jacl.2007.03.001 · Cited by 130
Daniels, L. B., Laughlin, G. A., Sarno, M., Bettencourt, R., Wolfert, R. L., & Barrett-Connor, E. L. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.10.048 · Cited by 128
Sandri, M. T., Cardinale, D. M., Zorzino, L., Passerini, R., Lentati, P., Martinoni, A., Martinelli, G., & Cipolla, C. M. (2003) · Clinical Chemistry · doi:10.1373/49.2.248 · Cited by 123
Lessons Learned From Recent Cardiovascular Clinical Trials: Part II
DeMets, D. L., & Califf, R. M. (2002) · Circulation · doi:10.1161/01.cir.0000023220.26465.89 · Cited by 123
Smallest LDL Particles Are Most Strongly Related to Coronary Disease Progression in Men
Holl, L. G., Krauss, R. M., Williams, P. T., Superko, H. R., Haskell, W. L., Alderman, E. L., Patricia, J., & Blanche, P. J. (2015) · Cited by 122
Profiles in Patient Safety: Confirmation Bias in Emergency Medicine
Pines, J. M. (2005) · Academic Emergency Medicine · doi:10.1197/j.aem.2005.07.028 · Cited by 119
MRI in treatment of adult gliomas
Henson, J. W., Gaviani, P., & González, R. G. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)01767-5 · Cited by 115
Validation of novel imaging methodologies for use as cancer clinical trial end-points
Sargent, D. J., Rubinstein, L., Schwartz, L. H., Dancey, J. E., Gatsonis, C. A., Dodd, L. E., & Shankar, L. K. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2008.10.030 · Cited by 114
LDL Size and Risk of Coronary Heart Disease in Elderly Men and Women
Mykkänen, L., Kuusisto, J., Haffner, S. M., Laakso, M., & Austin, M. A. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.11.2742 · Cited by 112
From differentiating metabolites to biomarkers
Koulman, A., Lane, G. A., Harrison, S. J., & Volmer, D. A. (2009) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-009-2690-3 · Cited by 111
Oxidative Stress in Cystic Fibrosis: Dietary and Metabolic Factors
Wood, L. G., Fitzgerald, D. A., Gibson, P. G., Cooper, D. M., Collins, C. E., & Garg, M. L. (2001) · Journal of the American College of Nutrition · doi:10.1080/07315724.2001.10719028 · Cited by 111
Clinical and Analytical Standardization Issues Confronting Cardiac Troponin I
Apple, F. S. (1999) · Clinical Chemistry · doi:10.1093/clinchem/45.1.18 · Cited by 109
Williams, B. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.10.069 · Cited by 108
Functional Foods: Opportunities & Challenges
Clydesdale, F. M. (2004) · Food technology · Cited by 108
Omission Bias and Decision Making in Pulmonary and Critical Care Medicine
Aberegg, S. K., Haponik, E. F., & Terry, P. B. (2005) · CHEST Journal · doi:10.1378/chest.128.3.1497 · Cited by 105
Predictors of pre-hospital delay among patients with acute myocardial infarction
Khraim, F., & Carey, M. G. (2008) · Patient Education and Counseling · doi:10.1016/j.pec.2008.09.019 · Cited by 105
Strategic paths for biomarker qualification
Goodsaid, F. M., Frueh, F. W., & Mattes, W. B. (2008) · Toxicology · doi:10.1016/j.tox.2007.12.023 · Cited by 104
Choi, H. (2005) · Current Oncology Reports · doi:10.1007/s11912-005-0055-4 · Cited by 100
Sometimes Size Doesn't Matter: Reevaluating RECIST and Tumor Response Rate Endpoints
Tuma, R. S. (2006) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djj403 · Cited by 100
CRP or not CRP? That Is the Question
Pepys, M. B. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000169644.88847.28 · Cited by 100
Apple, F. S., Wu, A. H. B., Jaffe, A. S., Panteghini, M., Christenson, R. H., Christenson, R. H., Apple, F. S., Cannon, C. P., Francis, G. S., Jesse, R. L., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.185266 · Cited by 98
on behalf of the CRISCOM Working Group, Julian‐Reynier, C., Welkenhuysen, M., Hagoel, L., Decruyenaere, M., & Hopwood, P. (2003) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201037 · Cited by 97
Meta-analysis for the evaluation of surrogate endpoints in cancer clinical trials
Shi, Q., & Sargent, D. J. (2009) · International Journal of Clinical Oncology · doi:10.1007/s10147-009-0885-4 · Cited by 94
Ullrich, R. T., Zander, T., Neumaier, B., Koker, M., Shimamura, T., Waerzeggers, Y., Borgman, C. L., Tawadros, S., Li, H., Sos, M. L., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003908 · Cited by 93
Watanabe, Y., Ito, T., & Shiomi, M. (1985) · Atherosclerosis · doi:10.1016/0021-9150(85)90085-1 · Cited by 92
EVALUATION OF DRUG TREATMENT IN MILD HYPERTENSION: VA‐NHLBI FEASIBILITY TRIAL*
Neurath, H. M., Goldman, A. I., Lavin, M. A., Schnaper, H. W., Fitz, A. E., Frohlich, E. D., Steele, B. W., & Richman, H. G. (1978) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1978.tb25604.x · Cited by 91
The Future of Antihypertensive Treatment
Israili, Z. H., Hernández-Hernández, R., & Valasco, M. (2007) · American Journal of Therapeutics · doi:10.1097/01.pap.0000249915.12185.58 · Cited by 91
Gritz, D. C., Srinivasan, M., Smith, S. D. G., Kim, U. R., Lietman, T. M., Wilkins, J. H., Priyadharshini, B., John, R. K., Aravind, S., Prajna, N. V., et al. (2006) · British Journal of Ophthalmology · doi:10.1136/bjo.2005.088104 · Cited by 91
Babiker, A. G., Bartlett, J., Breckenridge, A., Collins, G., Coombs, R. W., Cooper, D. A., Creagh, T., Cross, A. P., Daniels, M., Darbyshire, J., et al. (2000) · AIDS Research and Human Retroviruses · doi:10.1089/088922200414965 · Cited by 89
Antioxidants and cardiovascular disease: a review.
Manson, J. E., Gaziano, J. M., Jonas, M. A., & Hennekens, C. H. (1993) · Journal of the American College of Nutrition · doi:10.1080/07315724.1993.10718332 · Cited by 88
Alternate Endpoints for Screening Phase II Studies
Dhani, N. C., Tu, D., Sargent, D. J., Seymour, L., & Moore, M. J. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2034 · Cited by 87
Colburn, W. A. (2000) · The Journal of Clinical Pharmacology · doi:10.1177/009127000004001212 · Cited by 86
Major cardiovascular events in hypertensive patients randomized to doxazosin versus chlorthalidone
Kaplan, N. M., & Vidt, D. G. (2000) · Current Hypertension Reports · doi:10.1007/s11906-000-0022-2 · Cited by 86
A critical look at the evidence for the oxidation of LDL in atherogenesis
Steinberg, D. H. (1997) · Atherosclerosis · doi:10.1016/s0021-9150(97)06115-7 · Cited by 84
Concerns about numeracy skills of nursing students
Jukes, L., & Gilchrist, M. (2006) · Nurse Education in Practice · doi:10.1016/j.nepr.2005.12.002 · Cited by 83
Risk, Communication and Health Psychology
Berry, D. C. (2004) · Cited by 79
Against the Odds: The Story of AIDS, Drug Development, Politics and Profits
Taylor, R. C. R., Arno, P. S., & Feiden, K. L. (1993) · Contemporary Sociology A Journal of Reviews · doi:10.2307/2075715 · Cited by 79
Redefining Quality — Implications of Recent Clinical Trials
Krumholz, H. M., & Lee, T. H.-Y. (2008) · New England Journal of Medicine · doi:10.1056/nejmp0803740 · Cited by 79
Schectman, G., Patsches, M., & Sasse, E. A. (1996) · Clinical Chemistry · doi:10.1093/clinchem/42.5.732 · Cited by 75
CD4 cell count as a surrogate endpoint in HIV clinical trials
Hughes, M. D., Daniels, M. J., Fischl, M. A., Kim, S., & Schooley, R. T. (1998) · AIDS · doi:10.1097/00002030-199814000-00014 · Cited by 75
Clarke, R., Lewington, S., Sherliker, P., & Armitage, J. (2006) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e328011aa71 · Cited by 75
Weakness in numbers: The challenge of numeracy in health care
Montori, V. M., & Rothman, R. L. (2005) · Journal of General Internal Medicine · doi:10.1111/j.1525-1497.2005.051498.x · Cited by 74
Use and Misuse of Cardiac Troponins in Clinical Practice
Gupta, S. K., & de Lemos, J. A. (2007) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2007.01.002 · Cited by 74
Development of Target-Based Antineoplastic Agents
Stadler, W. M., & Ratain, M. J. (2000) · Investigational New Drugs · doi:10.1023/a:1006371512390 · Cited by 73
Robins, S. J. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)02148-8 · Cited by 73
Lopes-Virella, M. F. (2003) · Frontiers in bioscience · doi:10.2741/1141 · Cited by 72
The FDA as a Public Health Agency
Hamburg, M. A., & Sharfstein, J. M. (2009) · New England Journal of Medicine · doi:10.1056/nejmp0903764 · Cited by 72
The Biomarkers Consortium: On the Critical Path of Drug Discovery
Altar, C. A. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100471 · Cited by 72
Blood pressure as an example of a biomarker that functions as a surrogate
Desai, M. G., Stockbridge, N., & Temple, R. (2006) · The AAPS Journal · doi:10.1208/aapsj080117 · Cited by 71
The Value, Qualification, and Regulatory Use of Surrogate End Points in Drug Development
Lathia, C., Amakye, D. D., Dai, W., Girman, C. J., Madani, S., Mayne, J. T., MacCarthy, P., Pertel, P. E., SEMAN, L. J., Stoch, A., et al. (2009) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.69 · Cited by 71
Conventional and novel PET tracers for imaging in oncology in the era of molecular therapy
Pantaleo, M. A., Nannini, M., Maleddu, A., Fanti, S., Ambrosini, V., Nanni, C., Boschi, S., & Biasco, G. (2007) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2007.10.001 · Cited by 70
Expanding the Orbit of Primary Prevention — Moving beyond JUPITER
Hlatky, M. A. (2008) · New England Journal of Medicine · doi:10.1056/nejme0808320 · Cited by 69
Yaron, G., Brill, A. G., Dashevsky, O., Levi, I. M.-Y., Grad, E., Danenberg, H. D., & Varon, D. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06198.x · Cited by 68
Clinical implications of antiangiogenic therapies.
Sehn, L. H., & Connors, J. M. (2005) · PubMed · Cited by 67
How, when, and why to use apolipoprotein B in clinical practice
Sniderman, A. D. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02633-4 · Cited by 65
Atherogenesis and the humoral immune response to modified lipoproteins
Virella, G., & Lopes-Virella, M. F. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.03.025 · Cited by 63
A Prototypical Process for Creating Evidentiary Standards for Biomarkers and Diagnostics
Altar, C. A., Amakye, D. D., Bounos, D., et al. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100451 · Cited by 61
Consumer perspectives on food labels
Borra, S. T. (2006) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.5.1235s · Cited by 60
Health literacy, eHealth, and communication : putting the consumer first : workshop summary
Hernandez, L. M. (2009) · Cited by 59
Sakatani, T., Shirayama, T., Suzaki, Y., Yamamoto, T., Mani, H., Kawasaki, T., Sugihara, H., & Matsubara, H. (2005) · International Heart Journal · doi:10.1536/ihj.46.619 · Cited by 59
Dissecting Qualified Health Claims: Evidence From Experimental Studies
Hooker, N. H., & Teratanavat, R. (2008) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408390601177704 · Cited by 59
More effective nutrition label formats are not necessarily preferred
Levy, A. S., Fein, S. B., & Schucker, R. E. (1992) · Journal of the American Dietetic Association · doi:10.1016/s0002-8223(21)00863-4 · Cited by 57
(2010) · Nutrition & Food Science · doi:10.1108/nfs.2010.01740cab.009 · Cited by 57
Short-term Prognostic Value of Lipid Measurements in Patients with Angina pectoris
Bolíbar, I., Assmann, G., Thompson, S. G., von Eckardstein, A., & The ECAT Angina Pectoris Study Group (2000) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614155 · Cited by 55
Nordestgaard, B. G. (2009) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3283307bfe · Cited by 54
Sniderman, A. D., & Marcovina, S. M. (2006) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2006.07.007 · Cited by 54
Troponins in acute coronary syndromes
Scirica, B. M., & Morrow, D. A. (2004) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2004.07.004 · Cited by 51
The international standard for interleukin-6
Das, R., & Poole, S. (1993) · Journal of Immunological Methods · doi:10.1016/0022-1759(93)90172-4 · Cited by 51
Akl, E. A., Maroun, N., Guyatt, G. H., Oxman, A. D., Alonso‐Coello, P., Vist, G. E., Devereaux, P. J., Montori, V. M., & Schünemann, H. J. (2007) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2007.03.011 · Cited by 47
Delivery of High‐Quality Biomarker Assays
Swanson, B. N. (2002) · Disease Markers · doi:10.1155/2002/212987 · Cited by 47
A Collaborative Study to Establish the 2nd International Standard for Fibrinogen, Plasma
Whitton, C. M., Sands, D., Gaffney, P. J., & Hubbard, A. R. (2000) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614005 · Cited by 47
On a Low-density Lipoprotein Appearing in Normal Human Plasma.
Pedersen, K. O. (1947) · The Journal of Physical Chemistry · doi:10.1021/j150451a011 · Cited by 46
Breckenridge, A. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100079 · Cited by 44
Clinical, Diagnostic, and Therapeutic Aspects of Familial Hypercholesterolemia
Cohen, E., Jansen, A. C. M., de Jongh, S., et al. (2004) · Seminars in Vascular Medicine · doi:10.1055/s-2004-822984 · Cited by 44
Physician numeracy: essential skills for practicing evidence-based medicine.
Rao, G. (2008) · PubMed · Cited by 42
Heimbach, J. T., & Stokes, R. (1982) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/36.4.700 · Cited by 42
DOWNING, D. L. (1996) · Elsevier eBooks · doi:10.1533/9781845696191.123 · Cited by 41
Kim, H., Nakamura, C., & Zeng‐Treitler, Q. (2009) · Journal of Medical Internet Research · doi:10.2196/jmir.1129 · Cited by 40
BCR/IFCC reference material for plasma proteins (CRM 470)
Whicher, J. T. (1998) · Clinical Biochemistry · doi:10.1016/s0009-9120(98)00035-6 · Cited by 38
Kramer, D. B., Mallis, E., Zuckerman, B. D., Zimmerman, B., & Maisel, W. H. (2010) · American Journal of Therapeutics · doi:10.1097/mjt.0b013e3181ca8105 · Cited by 38
Beta Carotene Supplementation and Age-Related Maculopathy in a Randomized Trial of US Physicians
Christen, W. G., Manson, J. E., Glynn, R. J., Gaziano, J. M., Chew, E. Y., Buring Julie, E., & Hennekens, C. H. (2007) · Archives of Ophthalmology · doi:10.1001/archopht.125.3.333 · Cited by 36
Genetic Loci Associated With C-Reactive Protein Levels and Risk of Coronary Heart Disease
Elliott, P. (2009) · JAMA · doi:10.1001/jama.2009.954 · Cited by 35
Pediatric Approach to Hypertension
Brady, T. M., & Feld, L. G. (2009) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2009.03.014 · Cited by 35
Safe Medical Devices for Children
Institute of Medicine (2005) · National Academies Press eBooks · doi:10.17226/11313 · Cited by 32
Medicalisation, limits to medicine, or never enough money to go around?
Freemantle, N., & Hill, S. (2002) · BMJ · doi:10.1136/bmj.324.7342.864 · Cited by 32
Straßburg, J., Junginger, T., Trinh, T., Püttcher, O., Oberholzer, K., Heald, R. J., & Hermanek, P. (2008) · International Journal of Colorectal Disease · doi:10.1007/s00384-008-0531-z · Cited by 32
Shah, S. H., & de Lemos, J. A. (2009) · JAMA · doi:10.1001/jama.2009.949 · Cited by 32
Dose Density in Adjuvant Chemotherapy for Breast Cancer
Citron, M. L. (2004) · Cancer Investigation · doi:10.1081/cnv-200027134 · Cited by 32
Balancing the benefits of statins versus a new risk—diabetes
Cannon, C. P. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60234-6 · Cited by 31
Trial Registration Report Card
Drazen, J. M., & Wood, A. J. J. (2005) · New England Journal of Medicine · doi:10.1056/nejme058279 · Cited by 31
Biomarkers in Clinical Drug Development
Gobburu, J. (2009) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.57 · Cited by 30
Clinical Trials and Tribulations
Morgan, J. P. (1974) · Archives of Internal Medicine · doi:10.1001/archinte.1974.00320200190030 · Cited by 29
Hughes, M. D., DeGruttola, V., & Welles, S. L. (1995) · PubMed · Cited by 29
Roswarski, T. E., & Murray, M. D. (2006) · Medical Decision Making · doi:10.1177/0272989x06286483 · Cited by 28
Couzin, J. (2008) · Science · doi:10.1126/science.322.5899.220 · Cited by 28
The prognostic value of biomarkers after a premature myocardial infarction
Pineda, J., Marín, F. R., Marco, P., Roldán, V., Valencia, J., Ruiz-Nodar, J. M., Romero, D. H., Sogorb, F., & Lip, G. Y. H. (2009) · International Journal of Cardiology · doi:10.1016/j.ijcard.2009.02.019 · Cited by 26
Biomarkers in abdominal imaging
BEERS, B. E. V., & Vilgrain, V. (2008) · Abdominal Imaging · doi:10.1007/s00261-008-9480-9 · Cited by 25
FDA’s Review of Scientific Evidence for Health Claims
Schneeman, B. O. (2007) · Journal of Nutrition · doi:10.1093/jn/137.2.493 · Cited by 23
New biochemical markers: From bench to bedside
Zaninotto, M., Mion, M. M., Novello, E., Altinier, S., & Plebani, M. (2007) · Clinica Chimica Acta · doi:10.1016/j.cca.2007.02.028 · Cited by 20
Lutfey, K., & McKinlay, J. B. (2009) · Sociology of Health & Illness · doi:10.1111/j.1467-9566.2009.01181.x · Cited by 19
Kimberly, M. M., Caudill, S. P., Vesper, H. W., Monsell, E. A., Miller, W. G., Rej, R., Rifai, N., Dati, F., & Myers, G. L. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2008.115907 · Cited by 19
Management of hyperlipidemia with statins in the older patient
Aronow, W. S. (2006) · Clinical Interventions in Aging · doi:10.2147/ciia.2006.1.4.433 · Cited by 16
Difficult Decisions in the Intensive Care Unit: An Illustrative Case
Freshwater-Turner, D., Boots, R. J., Bowman, R. N., Healy, H. G., & Klestov, A. (2007) · Anaesthesia and Intensive Care · doi:10.1177/0310057x0703500515 · Cited by 15
Rosuvastatin in Patients with Elevated C-Reactive Protein
Gibbons, R. J. (2009) · New England Journal of Medicine · doi:10.1056/nejmc082574 · Cited by 15
Risk factors for mortality in users of ibopamine
Feenstra, J., Veld, B. A. I., van der Linden, P. D., Grobbee, D. E., & Stricker, B. H. C. (1998) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1998.00046.x · Cited by 15
Cancer as a Programmed Death of an Organism
Lichtenstein, A. V. (2005) · Biochemistry (Moscow) · doi:10.1007/s10541-005-0224-y · Cited by 15
Colatsky, T. J. (2009) · PubMed · Cited by 11
Role of Biomarkers in Developing New Therapies for Vascular Disease
Nambi, V., & Ballantyne, C. M. (2007) · World Journal of Surgery · doi:10.1007/s00268-006-0712-2 · Cited by 10
Novel approaches to treating cardiovascular disease: lessons from Tangier disease
Oram, J. F. (2001) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.10.3.427 · Cited by 10
Tamir, O., Lipschitz, Y., & Shemer, J. (2006) · New England Journal of Medicine · doi:10.1056/nejmc066024 · Cited by 7
Familial hypercholesterolaemia: optimum treatment strategies.
Ballantyne, C. M. (2002) · PubMed · Cited by 7
ENHANCE and ACCORD: Controversy over surrogate end points
Nissen, S. E. (2008) · Current Cardiology Reports · doi:10.1007/s11886-008-0027-z · Cited by 6
Blood Pressure as a Surrogate End Point for Hypertension
Carter, B. L. (2002) · Annals of Pharmacotherapy · doi:10.1345/aph.1a069 · Cited by 6
Califf, R. M., Pieper, K. S., Harlan, W. R., & Lee, K. L. (1992) · Annals of Epidemiology · doi:10.1016/1047-2797(92)90048-u · Cited by 4
FDA approval of Antiretroviral Agents: An Evolving Paradigm
Behrman, R. E. (1999) · Drug Information Journal · doi:10.1177/009286159903300202 · Cited by 1
Cited by
Mozaffarian, D. (2016) · Circulation · doi:10.1161/circulationaha.115.018585 · Cited by 2,216
Imaging biomarker roadmap for cancer studies
O'Connor, J. P. B., Aboagye, E. O., Adams, J. E., Aerts, H. J. W. L., Barrington, S. F., Beer, A. J., Boellaard, R., Bohndiek, S. E., Brady, M., Brown, G., et al. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.162 · Cited by 1,091
Biomarkers and surrogate endpoints in clinical trials
Fleming, T. R., & Powers, J. H. (2012) · Statistics in Medicine · doi:10.1002/sim.5403 · Cited by 544
Thurston, G. D., Kipen, H., Annesi-Maesano, I., Balmes, J., Brook, R. D., Cromar, K., De Matteis, S., Forastiere, F., Forsberg, B., Frampton, M. W., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.00419-2016 · Cited by 537
Treatment of stage IV periodontitis: The EFP S3 level clinical practice guideline
Herrera, D., Sanz, M., Kebschull, M., Jepsen, S., Sculean, A., Berglundh, T., Papapanou, P. N., Chapple, I., Tonetti, M. S., & Consultant, E. W. P. A. M. (2022) · Journal of Clinical Periodontology · doi:10.1111/jcpe.13639 · Cited by 408
Metadata
- Venue
- National Academies Press eBooks
- Publisher
- National Academies Press
- Published
- 2010-06-25
- OpenAlex
- W1496978731
- Cited by
- 276
- References
- 333
- FWCI
- 25.07
- Type
- book
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.